Global Biodegradable Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Biodegradable Embolic Microspheres market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biodegradable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Biodegradable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Biodegradable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Biodegradable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Biodegradable Embolic Microspheres include Varian, Jiangsu Hengrui Medicine, Terumo Corporation, Tepha, Teleflex, Promedics AG, Occlugel, Nippon Kayaku and Next Biomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biodegradable Embolic Microspheres, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Biodegradable Embolic Microspheres, also provides the sales of main regions and countries. Of the upcoming market potential for Biodegradable Embolic Microspheres, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biodegradable Embolic Microspheres sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Biodegradable Embolic Microspheres market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Biodegradable Embolic Microspheres sales, projected growth trends, production technology, application and end-user industry.

Biodegradable Embolic Microspheres Segment by Company

Varian
Jiangsu Hengrui Medicine
Terumo Corporation
Tepha
Teleflex
Promedics AG
Occlugel
Nippon Kayaku
Next Biomedical
Mermaid Medical
Merit Medical Systems
CeloNova BioSciences
BTG Corporate
Biosphere Medical
Biocompatibles
Angio Dynamics
ABK Biomedical
Biodegradable Embolic Microspheres Segment by Type

Visualization Type
Environmentally Responsive Type
Radioactive Type
Other
Biodegradable Embolic Microspheres Segment by Application

Research Institution
Hospitals And Clinics
Biodegradable Embolic Microspheres Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biodegradable Embolic Microspheres market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biodegradable Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biodegradable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Biodegradable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Biodegradable Embolic Microspheres Market Size, 2020 VS 2024 VS 2031
1.3 Global Biodegradable Embolic Microspheres Market Size Estimates and Forecasts (2020-2031)
1.4 Global Biodegradable Embolic Microspheres Sales Estimates and Forecasts (2020-2031)
1.5 Global Biodegradable Embolic Microspheres Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Biodegradable Embolic Microspheres Market Dynamics
2.1 Biodegradable Embolic Microspheres Industry Trends
2.2 Biodegradable Embolic Microspheres Industry Drivers
2.3 Biodegradable Embolic Microspheres Industry Opportunities and Challenges
2.4 Biodegradable Embolic Microspheres Industry Restraints
3 Biodegradable Embolic Microspheres Market by Manufacturers
3.1 Global Biodegradable Embolic Microspheres Revenue by Manufacturers (2020-2025)
3.2 Global Biodegradable Embolic Microspheres Sales by Manufacturers (2020-2025)
3.3 Global Biodegradable Embolic Microspheres Average Sales Price by Manufacturers (2020-2025)
3.4 Global Biodegradable Embolic Microspheres Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Biodegradable Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Biodegradable Embolic Microspheres Manufacturers, Product Type & Application
3.7 Global Biodegradable Embolic Microspheres Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Biodegradable Embolic Microspheres Market CR5 and HHI
3.8.2 Global Top 5 and 10 Biodegradable Embolic Microspheres Players Market Share by Revenue in 2024
3.8.3 2024 Biodegradable Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 Biodegradable Embolic Microspheres Market by Type
4.1 Biodegradable Embolic Microspheres Type Introduction
4.1.1 Visualization Type
4.1.2 Environmentally Responsive Type
4.1.3 Radioactive Type
4.1.4 Other
4.2 Global Biodegradable Embolic Microspheres Sales by Type
4.2.1 Global Biodegradable Embolic Microspheres Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Biodegradable Embolic Microspheres Sales by Type (2020-2031)
4.2.3 Global Biodegradable Embolic Microspheres Sales Market Share by Type (2020-2031)
4.3 Global Biodegradable Embolic Microspheres Revenue by Type
4.3.1 Global Biodegradable Embolic Microspheres Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Biodegradable Embolic Microspheres Revenue by Type (2020-2031)
4.3.3 Global Biodegradable Embolic Microspheres Revenue Market Share by Type (2020-2031)
5 Biodegradable Embolic Microspheres Market by Application
5.1 Biodegradable Embolic Microspheres Application Introduction
5.1.1 Research Institution
5.1.2 Hospitals And Clinics
5.2 Global Biodegradable Embolic Microspheres Sales by Application
5.2.1 Global Biodegradable Embolic Microspheres Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Biodegradable Embolic Microspheres Sales by Application (2020-2031)
5.2.3 Global Biodegradable Embolic Microspheres Sales Market Share by Application (2020-2031)
5.3 Global Biodegradable Embolic Microspheres Revenue by Application
5.3.1 Global Biodegradable Embolic Microspheres Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Biodegradable Embolic Microspheres Revenue by Application (2020-2031)
5.3.3 Global Biodegradable Embolic Microspheres Revenue Market Share by Application (2020-2031)
6 Global Biodegradable Embolic Microspheres Sales by Region
6.1 Global Biodegradable Embolic Microspheres Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Biodegradable Embolic Microspheres Sales by Region (2020-2031)
6.2.1 Global Biodegradable Embolic Microspheres Sales by Region (2020-2025)
6.2.2 Global Biodegradable Embolic Microspheres Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Biodegradable Embolic Microspheres Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Biodegradable Embolic Microspheres Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Biodegradable Embolic Microspheres Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Biodegradable Embolic Microspheres Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Biodegradable Embolic Microspheres Revenue by Region
7.1 Global Biodegradable Embolic Microspheres Revenue by Region
7.1.1 Global Biodegradable Embolic Microspheres Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Biodegradable Embolic Microspheres Revenue by Region (2020-2025)
7.1.3 Global Biodegradable Embolic Microspheres Revenue by Region (2026-2031)
7.1.4 Global Biodegradable Embolic Microspheres Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Biodegradable Embolic Microspheres Revenue (2020-2031)
7.2.2 North America Biodegradable Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Biodegradable Embolic Microspheres Revenue (2020-2031)
7.3.2 Europe Biodegradable Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Biodegradable Embolic Microspheres Revenue (2020-2031)
7.4.2 Asia-Pacific Biodegradable Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Biodegradable Embolic Microspheres Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Biodegradable Embolic Microspheres Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Varian
8.1.1 Varian Comapny Information
8.1.2 Varian Business Overview
8.1.3 Varian Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Varian Biodegradable Embolic Microspheres Product Portfolio
8.1.5 Varian Recent Developments
8.2 Jiangsu Hengrui Medicine
8.2.1 Jiangsu Hengrui Medicine Comapny Information
8.2.2 Jiangsu Hengrui Medicine Business Overview
8.2.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio
8.2.5 Jiangsu Hengrui Medicine Recent Developments
8.3 Terumo Corporation
8.3.1 Terumo Corporation Comapny Information
8.3.2 Terumo Corporation Business Overview
8.3.3 Terumo Corporation Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio
8.3.5 Terumo Corporation Recent Developments
8.4 Tepha
8.4.1 Tepha Comapny Information
8.4.2 Tepha Business Overview
8.4.3 Tepha Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Tepha Biodegradable Embolic Microspheres Product Portfolio
8.4.5 Tepha Recent Developments
8.5 Teleflex
8.5.1 Teleflex Comapny Information
8.5.2 Teleflex Business Overview
8.5.3 Teleflex Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Teleflex Biodegradable Embolic Microspheres Product Portfolio
8.5.5 Teleflex Recent Developments
8.6 Promedics AG
8.6.1 Promedics AG Comapny Information
8.6.2 Promedics AG Business Overview
8.6.3 Promedics AG Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Promedics AG Biodegradable Embolic Microspheres Product Portfolio
8.6.5 Promedics AG Recent Developments
8.7 Occlugel
8.7.1 Occlugel Comapny Information
8.7.2 Occlugel Business Overview
8.7.3 Occlugel Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Occlugel Biodegradable Embolic Microspheres Product Portfolio
8.7.5 Occlugel Recent Developments
8.8 Nippon Kayaku
8.8.1 Nippon Kayaku Comapny Information
8.8.2 Nippon Kayaku Business Overview
8.8.3 Nippon Kayaku Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio
8.8.5 Nippon Kayaku Recent Developments
8.9 Next Biomedical
8.9.1 Next Biomedical Comapny Information
8.9.2 Next Biomedical Business Overview
8.9.3 Next Biomedical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Next Biomedical Biodegradable Embolic Microspheres Product Portfolio
8.9.5 Next Biomedical Recent Developments
8.10 Mermaid Medical
8.10.1 Mermaid Medical Comapny Information
8.10.2 Mermaid Medical Business Overview
8.10.3 Mermaid Medical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio
8.10.5 Mermaid Medical Recent Developments
8.11 Merit Medical Systems
8.11.1 Merit Medical Systems Comapny Information
8.11.2 Merit Medical Systems Business Overview
8.11.3 Merit Medical Systems Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio
8.11.5 Merit Medical Systems Recent Developments
8.12 CeloNova BioSciences
8.12.1 CeloNova BioSciences Comapny Information
8.12.2 CeloNova BioSciences Business Overview
8.12.3 CeloNova BioSciences Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio
8.12.5 CeloNova BioSciences Recent Developments
8.13 BTG Corporate
8.13.1 BTG Corporate Comapny Information
8.13.2 BTG Corporate Business Overview
8.13.3 BTG Corporate Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 BTG Corporate Biodegradable Embolic Microspheres Product Portfolio
8.13.5 BTG Corporate Recent Developments
8.14 Biosphere Medical
8.14.1 Biosphere Medical Comapny Information
8.14.2 Biosphere Medical Business Overview
8.14.3 Biosphere Medical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio
8.14.5 Biosphere Medical Recent Developments
8.15 Biocompatibles
8.15.1 Biocompatibles Comapny Information
8.15.2 Biocompatibles Business Overview
8.15.3 Biocompatibles Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Biocompatibles Biodegradable Embolic Microspheres Product Portfolio
8.15.5 Biocompatibles Recent Developments
8.16 Angio Dynamics
8.16.1 Angio Dynamics Comapny Information
8.16.2 Angio Dynamics Business Overview
8.16.3 Angio Dynamics Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio
8.16.5 Angio Dynamics Recent Developments
8.17 ABK Biomedical
8.17.1 ABK Biomedical Comapny Information
8.17.2 ABK Biomedical Business Overview
8.17.3 ABK Biomedical Biodegradable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio
8.17.5 ABK Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Biodegradable Embolic Microspheres Value Chain Analysis
9.1.1 Biodegradable Embolic Microspheres Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Biodegradable Embolic Microspheres Production Mode & Process
9.2 Biodegradable Embolic Microspheres Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Biodegradable Embolic Microspheres Distributors
9.2.3 Biodegradable Embolic Microspheres Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings